Valuation (100%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.02 | N/A |
| PEG Ratio (TTM) | 0.14 | N/A |
| P/S Ratio (TTM) | 0.07 | N/A |
| P/B Ratio (TTM) | 0.24 | N/A |
| P/FCF Ratio (TTM) | 1.37 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.79 | N/A |
| Price to 5YR AVG FCF Ratio | 2.28 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.80% | N/A |
| ROE (TTM) | 10.55% | N/A |
| Net Profit Margin (TTM) | 1.01% | N/A |
| ROIC 5YR AVG | 5.71% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 188.49% | 285.49% | 173.47% |
| Revenue | 1.46% | 16.19% | 13.98% |
| Net Income | 190.84% | 141.21% | 86.90% |
| Cash Flow | 279.94% | -3.91% | 4.45% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | N/A |
| Quick Ratio (TTM) | 0.92 | N/A |
| D/E Ratio (TTM) | 0.54 | N/A |
| Interest Coverage (TTM) | 4.48 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.06 | N/A |
| LTL to 5YR AVG FCF | 4.82 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.98% | N/A |